openPR Logo
Press release

Drug Screening Market to Perceive Excellent CAGR of 17.3% by 2029, Size, Share, Growth Rate, Emerging Trends, Development Status and Revenue

09-27-2023 11:15 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Drug Screening Market to Perceive Excellent CAGR of 17.3%

The market study carried out in the finest Drug Screening Market report analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Moreover, analysis and estimation of important industry trends, market size, and market share are also covered in this market report. Drug Screening Market research report forecasts the size of the market with respect to the information on main retailer revenues, development of the Healthcare industry by upstream and downstream, industry progress, key companies, along with market segments and application.

Global drug screening market was valued at USD 5.3 billion in 2021 and is expected to reach USD 18.99 billion by 2029, registering a CAGR of 17.3% during the forecast period of 2022-2029. The "urine" accounts for the largest sample type segment in the drug screening market within the forecasted period owing to the benefits it offers such as cost-effectiveness, high detection accuracy of multiple drugs and instant results. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Visit full Study Report @

Drug Screening Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:


Growing Drugs Consumption

The rising consumption of illicit drugs is also expected to accelerate the market's overall growth as they further increase the adoption of drug screening products and services on the road. Moreover, the illegal drug use by teens will bolster the market growth.

Furthermore, the screening is easy to implement, thus offering flexible and effective workplace drug testing, which is also expected to fuel market growth. The increase in governmental funding to control drug trafficking is a significant factor that is projected to cushion the market's growth. The increasing road accidents due to overdose of drugs while driving and prescription drug misuse will further expand the drug screening market's growth rate in the future.

Restraints/Challenges Global Drug Screening Market

Prohibition of Drug Testing

The drug testing at some places (especially at workplace) is considered as a violation of employee privacy, which is expected to obstruct market growth.

The ban in consumption of drugs in certain places and accuracy issues related to breathalyzers are projected to challenge the drug screening market in the forecast period of 2022-2029.

Some of the major players operating in the drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US),  OraSure Technologies, Inc. (US), Siemens (Germany),  F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory Inc., (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), Sciteck, Inc. (US), Synens SAS (France), Intoximeters (US), AccuSource Inc., (US), Cordant Health Solutions (US), and Millennium Health (US) among others.

Recent Developments

In August 2021, Select Health of South Carolina and Quest Diagnostics have reached an agreement to expand Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees and improve members' access diagnostics information services.

Global Drug Screening Market Scope

The drug screening market is segmented on the basis of product and services, sample type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

Rapid Testing Devices (RTD)
Laboratory Services

On the basis of product and services, the drug screening market is segmented into equipment, rapid testing devices (RTD), consumables and laboratory services. Equipment is further sub segmented into immunoassay analyzers, chromatography instruments, and breath analyzers.  Breath analyzers is further sub segmented into semiconductor breath analyzers and fuel cell analyzers. Rapid testing devices (RTD) is further sub segmented into oral fluid testing devices and urine testing devices. Consumables is further sub segmented into assay kits, calibrators and controls, and sample collection cups.

Sample Type

Oral Fluid or Saliva
Other Samples

On the basis of sample type, the drug screening market is segmented into oral fluid or saliva, breath, hair, urine and other samples. Urine sample is projected to dominate the market owing to the benefits it offers such as cost-effectiveness, high detection accuracy of multiple drugs and instant results.

End User

Workplace and Schools
Criminal Justice Systems and Law Enforcement Agencies
Drug Testing Laboratories
Drug Treatment Centers
Personal Users
Pain Management Centers

On the basis of end user, the drug screening market is bifurcated into workplace and schools, criminal justice systems and law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, personal users and pain management centers.

Let's discuss the specifics of the report, including what you will receive and how it can benefit you:

It is crucial to identify audiences before beginning a campaign. In addition to this vital to know which countries to penetrate, we can provide you information.
It allows you to determine where to focus your efforts and which regions competition are located. You will be looking at the global market scenario, along with the GDP Growth of Drug Screening Market  that particular region. In this way, an accurate assessment of the global market is made possible.
To stay competitive, every organization must stay one step ahead. By working with us, you will get a better understanding of your competitors.
You will also be presented with several competitive profiles, along with their updated financials, latest R&D developments, and projected growth for the next few years. We will also be informing you about recent developments to keep you up-to-date and allow you to take appropriate action.
Besides analyzing the segments and growth rates, we will also help you find out the key players in this industry and identify what previous developments have taken place. To help you focus on the right segments, we will provide a 360-degree snapshot of this market.

Browse More Reports

About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: -

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Screening Market to Perceive Excellent CAGR of 17.3% by 2029, Size, Share, Growth Rate, Emerging Trends, Development Status and Revenue here

News-ID: 3226643 • Views: 107

More Releases from Data Bridge Market Research

Electric Blankets Market Size to Surpass USD 1,864.13 Million by 2029, Share, Growth, Demand, Global Trends, Challenges and Competitive Outlook
Electric Blankets Market Size to Surpass USD 1,864.13 Million by 2029, Share, Gr …
Market definition included in the world class Electric Blankets Market report explores the market drivers which indicate the factors causing rise in the market growth and market restraints which indicate the factors causing fall in the market growth. This industry report gives precise study of the Electric Blankets Market industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. The report offers CAGR value fluctuations
Down and Feather Market to Observe Utmost CAGR 7.15% by 2029, Size, Share, Demand, Key Drivers, Development Trends and Competitive Outlook
Down and Feather Market to Observe Utmost CAGR 7.15% by 2029, Size, Share, Deman …
To get success in this competitive market place, businesses consider taking up innovative solutions and market research report is one of them. All the data and information included in the world class Down and Feather Market report is extracted from incredibly reliable sources such as websites, annual reports of the companies, white papers, journals, newspapers, and mergers. Moreover, this market report gives idea to clients about the market drivers and
Curry Powder Market is Likely to Upsurge CAGR of 6.60% by 2029, Size, Share, Trends, Demand, Growth Forecast and Challenges
Curry Powder Market is Likely to Upsurge CAGR of 6.60% by 2029, Size, Share, Tre …
The reliable Curry Powder Market business report displays important product developments and tracks recent acquisitions, mergers and research in the Curry Powder Market industry by the major players. The report helps make known uncertainties that may come up due to changes in business activities or introduction of a new product in the market. Moreover, all the stats, data, facts and figures collected to prepare this market report are obtained from
Hypoprothrombinemia Treatment Market CAGR of 4.50% by 2029, Growth Opportunities, Driver, Restraints and Revenue Insights
Hypoprothrombinemia Treatment Market CAGR of 4.50% by 2029, Growth Opportunities …
Being a detailed market research report, Hypoprothrombinemia Treatment Market document furnishes the business and gives competitive advantage. This market research report brings into picture comprehensive analysis of the market structure along with estimations of the various segments and sub-segments of the market for Healthcare industry. This market report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. The world class Hypoprothrombinemia Treatment Market report also

All 5 Releases

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug